biotime inc (BTX:NYSE Amex)
Abraham E. Cohen
Former Director, Member of Audit Committee, Member of Compensation Committee and Member of Nominating/Corporate Governance Committee, BioTime, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 11 different industries.|
Mr. Abraham E. Cohen, Barry served as the Chairman of the Board and President of Kramex Company. Mr. Cohen served as an International Business Consultant since January 1992. Mr. Cohen was a Consultant to The Population Council and Chugai Pharmaceutical Co. Ltd. He served at Viragen Inc. and at Valeant Pharmaceuticals International. He served as Senior Vice President of Merck & Co. from 1982 to 1992. From 1977 to 1988, Mr. Cohen served as the President of Merck Sharp ...
1301 Harbor Bay ParkwayPhone: 510-521-3390
Alameda, California 94502
Board Members Memberships*
Former Chairman of the International Advisory Council, Director and Chairman of Chugai Pharma USA
Former Director, Member of Human Resources & Compensation Committee, Member of Corporate Governance & Nominating Committee
Former Chairman and Member of Compensation Committee
Former Director and Member of Compensation Committee
Former Director, Member of Audit Committee, Member of Compensation Committee and Member of Nominating/Corporate Governance Committee
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Gil Van Bokkelen Ph.D.||Co-Founder, Chairman and Chief Executive Officer|
|Marc H. Hedrick M.D.||Chief Executive Officer, President, Director and Member of Executive Committee|
Cytori Therapeutics, Inc.
|Robin L. Smith M.D., MBA,Ro||Executive Chairman and Chief Executive Officer|
|David M. Pernock||Chairman, Chief Executive Officer and President|
Fibrocell Science, Inc.
|Paul K. Wotton Ph.D.||Chief Executive Officer and President|
Advanced Cell Technology Inc.
|--||Compensation as of Fiscal Year 2013.|